Condition: Liver Diseases, Alcoholic · Alcohol Use Disorder · Treatment Adherence · Sponsor: Zealand University Hospital
To evaluate the efficacy of systematically offering newly diagnosed ALD patients to AUD treatment, in the hepatology clinic, on alcohol abstinence after 6 months. The investigators will conduct a randomized controlled superiority trial with parallel group design, hypothesis blinding and blinded outcome assessment comparing A) a offer to specialized AUD treatment (intervention) and B) standard care (control). Existing observational cohort ALD members will contribute to the control group in addition to the randomized controls. The primary outcome is abstinence throughout the last 30 days assessed 6 months after randomization.
This description comes directly from the study's public registry record.
Emil B B Fromberg, Cand.scient.san · 51184036 · ebuf@regionsjaelland.dk
Gro Askgaard, PhD · 60142280 · gras@regionsjaelland.dk
Always discuss trial participation with your own doctor first.
| Department of Medicine, Zealand University Hospital | Køge, Køge, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06493773